GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹1,047 Cr | ₹-1,502 Cr | ₹297 Cr | ₹942 Cr | ₹970 Cr |
What is the latest Consolidated Net Profit of GLENMARK PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹1,047 Cr |
| Mar2025 | ₹-1,502 Cr |
| Mar2024 | ₹297 Cr |
| Mar2023 | ₹942 Cr |
| Mar2022 | ₹970 Cr |
How is Consolidated Net Profit of GLENMARK PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,047 Cr | Positive | |
| Mar2025 | ₹-1,502 Cr | Negative | |
| Mar2024 | ₹297 Cr | -68.44 | |
| Mar2023 | ₹942 Cr | -2.92 | |
| Mar2022 | ₹970 Cr | - | |
Compare Consolidated Net Profit of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹68,204.9 Cr | -1.8% | 5.4% | 17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.8% |
5.4% |
17.8% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses